News

Old drugs and new treatments

15/09/2020

Bart Lambrecht (VIB-UGent Center for Inflammation research) has taken the lead in several clinical trials that are running under the promotorship of University Hospital Ghent across Belgium, in partnership with VIB. Some trials repurpose existing drugs to treat patients infected with COVID-19. A first trial is evaluating the effect of inhaled Leukine® on lung function and patient outcomes. A second approach focuses on several existing rheumatism medications to alleviate the excessive inflammatory reaction in severely affected COVID-19 patients. Two other trials employ new drugs to target the pro-inflammatory and  pro-coagulant complement system. 

FWO awards Excellence Prizes to two VIB researchers

24/06/2020

Every five years, the Research Foundation Flanders (FWO) awards the prestigious Excellence Prizes to eminent Flemish researchers with a distinguished career in science. In 2020, two VIB researchers working at Ghent University have received this important recognition for their outstanding scientific career and dedication to research: Prof. Bart Lambrecht (VIB-UGent Center for Inflammation Research) and prof. Wout Boerjan (VIB-UGent Center for Plant Systems Biology).

3 projects selected in VIB grand challenges program, additional projects may follow after new call

17/07/2018

The VIB Grand Challenges Program is a translational research program with which we aim to significantly increase the societal impact of VIB. We are convinced that this can be done by teaming up with experts outside VIB who have complementary expertise (clinic, agriculture, engineering …). Together we can exploit our knowledge, expertise and toolbox to generate new, otherwise untapped avenues to create added value for society. Three projects were selected and will receive funding up to 2.5 M€. We look forward to the outcome of these collaborations!

Competitive ERC Advanced Grant awarded to Bart Lambrecht to study the role of protein crystallization in asthma

06/04/2018

Prof. Bart Lambrecht (VIB-UGent Center for Inflammation Research) is awarded an Advanced Grant. To qualify, a scientist has to be able to prove exceptional leadership and a solid track record of significant research achievements over at least 10 years.  To leverage their impact, individual ERC grants provide considerable amounts of money, up to €2,5million for an Advanced Grant, for example. With a budget like that, researchers can embark on a dream project that would otherwise remain out of reach.